Simon Robinson compensation by year
Lantheus Summary Compensation Table · the one fiscal year held| Component | FY2019 |
|---|---|
| Salary | $337,588 |
| Bonus | $0 |
| Stock awards | $511,032 |
| Option awards | $0 |
| Non-equity incentive | $149,001 |
| Pension and deferred compensation | $0 |
| All other | $12,600 |
| Total | $1,010,221 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lantheus Holdings, Inc. DEF 14A filed March 12, 2020, accession 0001193125-20-071630, and prior-year filings.
How this page was built: the Lantheus Holdings, Inc. filed document, accession 0001193125-20-071630. Every figure is read from that document and cited to the page and table it appears in. Filed March 12, 2020.
Lantheus’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Mary Anne Heino | President and Chief Executive Officer | $4,320,908 |
| Robert Marshall Jr. | Chief Financial Officer | $1,435,394 |
| Michael Duffy | Senior Vice President, Law and Public Policy and General Counsel | $1,296,700 |
| Cesare Orlandi | Former Chief Medical Officer | $1,064,571 |
| John Bolla | Chief Operations Officer | $1,044,888 |
| Simon Robinson · this page | Senior Vice President, Research and Pharma Development | $1,010,221 |
The full Lantheus compensation record
free company briefThis page is one person within Lantheus's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Lantheus proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Lantheus's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.